Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study
Background: There are limited data on DTG-associated weight gain among treatment-naïve Asian people living with HIV (PLHIV). Methods: Eighty-one and 100 PLHIV initiating DTG-based and efavirenz (EFV)-based antiretroviral therapy (ART), respectively, were retrospectively investigated for weight chang...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Journal of Infection and Public Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034124003642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832592806805241856 |
|---|---|
| author | Rachawit Setpakdee Sasisopin Kiertiburanakul |
| author_facet | Rachawit Setpakdee Sasisopin Kiertiburanakul |
| author_sort | Rachawit Setpakdee |
| collection | DOAJ |
| description | Background: There are limited data on DTG-associated weight gain among treatment-naïve Asian people living with HIV (PLHIV). Methods: Eighty-one and 100 PLHIV initiating DTG-based and efavirenz (EFV)-based antiretroviral therapy (ART), respectively, were retrospectively investigated for weight changes and lipid profiles at 6 and 12 months after ART initiation. Results: At baseline, the DTG group had a lower mean body weight (BW) (60.7 kg vs. 64.3 kg, p = 0.071) and lower mean cholesterol level (172 mg/dL vs. 185 mg/dL, p = 0.029) than the EFV group. Mean BW remained lower in the DTG group than in the EFV group at 6 [58.2 kg vs. 66.0 kg, mean difference (MD) −7.8, p = 0.005] and 12 (59.6 kg vs. 67.0 kg, MD −7.3, p = 0.008) months. BW did not significantly change between baseline and 12 months in the DTG group (60.7 kg vs. 59.6 kg, p = 0.495), whereas it significantly increased between baseline and 12 months in the EFV group (64.3 kg vs. 66.9 kg, p = 0.019). Cholesterol levels did not significantly increase between baseline and 12 months in either group. After adjustment, DTG use [MD −5.85, 95 % confidence interval (CI) −10.45, −1.24, p = 0.013] and baseline BW (MD 0.97, 95 % CI 0.79, 1.15, p < 0.001) were significantly associated with BW changes over time. Conclusions: DTG-based ART was not significantly associated with increased BW and cholesterol levels compared with EFV-based ART in treatment-naïve Thai PLHIV. |
| format | Article |
| id | doaj-art-a6810149f5624c1691bdeb57b47a5f85 |
| institution | Kabale University |
| issn | 1876-0341 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Infection and Public Health |
| spelling | doaj-art-a6810149f5624c1691bdeb57b47a5f852025-01-21T04:12:57ZengElsevierJournal of Infection and Public Health1876-03412025-02-01182102630Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort studyRachawit Setpakdee0Sasisopin Kiertiburanakul1Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok 10400, ThailandCorrespondence to: Deparment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok 10400, ThailandBackground: There are limited data on DTG-associated weight gain among treatment-naïve Asian people living with HIV (PLHIV). Methods: Eighty-one and 100 PLHIV initiating DTG-based and efavirenz (EFV)-based antiretroviral therapy (ART), respectively, were retrospectively investigated for weight changes and lipid profiles at 6 and 12 months after ART initiation. Results: At baseline, the DTG group had a lower mean body weight (BW) (60.7 kg vs. 64.3 kg, p = 0.071) and lower mean cholesterol level (172 mg/dL vs. 185 mg/dL, p = 0.029) than the EFV group. Mean BW remained lower in the DTG group than in the EFV group at 6 [58.2 kg vs. 66.0 kg, mean difference (MD) −7.8, p = 0.005] and 12 (59.6 kg vs. 67.0 kg, MD −7.3, p = 0.008) months. BW did not significantly change between baseline and 12 months in the DTG group (60.7 kg vs. 59.6 kg, p = 0.495), whereas it significantly increased between baseline and 12 months in the EFV group (64.3 kg vs. 66.9 kg, p = 0.019). Cholesterol levels did not significantly increase between baseline and 12 months in either group. After adjustment, DTG use [MD −5.85, 95 % confidence interval (CI) −10.45, −1.24, p = 0.013] and baseline BW (MD 0.97, 95 % CI 0.79, 1.15, p < 0.001) were significantly associated with BW changes over time. Conclusions: DTG-based ART was not significantly associated with increased BW and cholesterol levels compared with EFV-based ART in treatment-naïve Thai PLHIV.http://www.sciencedirect.com/science/article/pii/S1876034124003642AIDSBody weightCholesterolDolutegravirHIV |
| spellingShingle | Rachawit Setpakdee Sasisopin Kiertiburanakul Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study Journal of Infection and Public Health AIDS Body weight Cholesterol Dolutegravir HIV |
| title | Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study |
| title_full | Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study |
| title_fullStr | Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study |
| title_full_unstemmed | Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study |
| title_short | Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study |
| title_sort | effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with hiv a retrospective cohort study |
| topic | AIDS Body weight Cholesterol Dolutegravir HIV |
| url | http://www.sciencedirect.com/science/article/pii/S1876034124003642 |
| work_keys_str_mv | AT rachawitsetpakdee effectofdolutegravironweightchangesandlipidprofilecomparedwithefavirenzinpeoplelivingwithhivaretrospectivecohortstudy AT sasisopinkiertiburanakul effectofdolutegravironweightchangesandlipidprofilecomparedwithefavirenzinpeoplelivingwithhivaretrospectivecohortstudy |